Strict control of comorbidities in patients with chronic obstructive pulmonary disease decreases exacerbations, morbimortality, and avoids readmissions. An increasing number of women have the disease, ...
Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. It is a leading cause of morbidity and ...
This educational activity is intended for pulmonary specialists and other members of the health care team who care for patients with obstructive lung diseases such as COPD and asthma. Asthma and COPD ...
In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...
India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...
A 40-year-old woman who was a frequent traveler suddenly found herself struggling to breathe after taking just a few steps. What began as unexplained fatigue and shortness of breath quickly disrupted ...
Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of symptoms like breathlessness, persistent cough, and fatigue is vital. This allows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback